Amicus Founder Named CEO of BIO
John Crowley, founder of Princeton-based Amicus Therapeutics, a company that is developing needed cures and innovations, was named the new CEO of BIO. BIO is the world’s largest trade association representing biotechnology companies. Amicus is a graduate of the Incubator at North Brunswick.
Aucta Pharma Launches MOTPOLY for Seizure Treatment
Incubator at North Brunswick graduate, Aucta Pharmaceuticals, recently introduced MOTPOLY XR, an innovative once-daily treatment for partial-onset seizures in adults and pediatric patients.
NJBIO Inc. Awarded Best CRO
Incubator at North Brunswick graduate, NJBIO Inc., recently announced that it was the recipient of the “Best Contract Research Organization” Award at the 10th Annual World ADC Awards.
Crystal Pharmatech Announce Partnership with CATUG
The two specialized organizations will provide clients with comprehensive nucleic acid services and analytical solutions in the North American market. Crystal Pharmatech is a graduate of the Incubator at North Brunswick.
Pharmanest Published In Liver International
Tthe company’s research, led by Dr. Mathieu Petithjean, recently made the cover page of the peer reviewed journal Liver International. Princeton based Pharmanest is a graduate of the Incubator at North Brunswick.
|